Search results
Results from the WOW.Com Content Network
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) or (in the United States) Lou Gehrig's disease (LGD), is a rare, terminal neurodegenerative disorder that results in the progressive loss of both upper and lower motor neurons that normally control voluntary muscle contraction. [3]
Excitotoxicity may be involved in cancers, spinal cord injury, stroke, traumatic brain injury, hearing loss (through noise overexposure or ototoxicity), and in neurodegenerative diseases of the central nervous system such as multiple sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, alcoholism, alcohol ...
Brooke Eby shares her Lou Gehrig’s disease, or ALS, diagnosis at age 33 and details her outlook on life after getting a terminal prognosis in her 30s. I thought I was too young to have ALS. Then ...
Researchers identified a new biomarker for predicting the clinical outcome of patients with ALS, Amyotrophic Lateral Sclerosis, through brain imaging. Researchers Say This Test Can Predict ALS ...
Symptoms of motor neuron diseases can be first seen at birth or can come on slowly later in life. Most of these diseases worsen over time; while some, such as ALS, shorten one's life expectancy, others do not. [2] Currently, there are no approved treatments for the majority of motor neuron disorders, and care is mostly symptomatic. [2]
The disease can affect people of all ages, but symptoms most often develop in people between the ages of 55 and 75, per the NIH. The exact cause is unknown, but genetics are thought to play a role ...
The brain requires the use of many neurosteroids to develop and function properly. These molecules are often identified as one of many common substances including thyroid hormones, glucocorticoids, and sex hormones. However in recent studies, throughout the brain and spinal fluid, vitamin D has begun to surface as one of these neurosteroids.
Mark, a Pennsylvania grandfather with ALS, is participating in a human trial with Synchron and is one of the first patients to be implanted with a brain-computer interface with the company. - CNN